John Hester
Stock Analyst at Bell Potter
(3.88)
# 1,804
Out of 4,592 analysts
209
Total ratings
46.6%
Success rate
7.7%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: PNV PolyNovo Limited | Downgraded: Hold | $1.80 → $1.00 | $0.87 | +15.61% | 12 | Jul 24, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $19.00 | $14.21 | +33.71% | 32 | Jul 21, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Maintained: Hold | $3.00 | $2.94 | +2.04% | 5 | Jul 19, 2026 | |
| ASX: MSB Mesoblast Limited | Upgraded: Buy | $4.45 | $2.05 | +117.07% | 20 | Jul 12, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.09 | $0.57 | +91.23% | 7 | Jul 12, 2026 | |
| ASX: CYC Cyclopharm Limited | Maintained: Buy | $1.00 | $0.59 | +70.94% | 14 | Jul 6, 2026 | |
| ASX: EIQ Echo IQ Limited | Downgraded: Hold | $1.65 → $1.75 | $1.33 | +32.08% | 2 | Jul 3, 2026 | |
| ASX: PAR Paradigm Biopharmaceuticals Limited | Maintained: Buy | $0.65 → $0.45 | $0.17 | +172.73% | 10 | Jun 18, 2026 | |
| ASX: PGC Paragon Care Limited | Downgraded: Hold | $0.30 → $0.17 | $0.13 | +36.00% | 17 | Jun 2, 2026 | |
| ASX: 4DX 4DMedical Limited | Maintained: Buy | $4.50 → $6.00 | $3.63 | +65.29% | 13 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.25 | $0.09 | +194.12% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $0.20 → $0.24 | $0.11 | +118.18% | 4 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $240.00 → $226.00 | $162.21 | +39.33% | 15 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.40 → $6.50 | $2.37 | +174.26% | 19 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.00 → $13.00 | $11.29 | +15.15% | 4 | Mar 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $4.10 → $3.60 | $3.14 | +14.65% | 16 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.05 → $0.06 | $0.01 | +328.57% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.02 | +733.33% | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.00 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.79 → $3.79 | $4.81 | n/a | 3 | Nov 25, 2022 |
PolyNovo Limited
Jul 24, 2026
Downgraded: Hold
Price Target: $1.80 → $1.00
Current: $0.87
Upside: +15.61%
Telix Pharmaceuticals Limited
Jul 21, 2026
Maintained: Buy
Price Target: $19.00
Current: $14.21
Upside: +33.71%
Sigma Healthcare Limited
Jul 19, 2026
Maintained: Hold
Price Target: $3.00
Current: $2.94
Upside: +2.04%
Mesoblast Limited
Jul 12, 2026
Upgraded: Buy
Price Target: $4.45
Current: $2.05
Upside: +117.07%
Aroa Biosurgery Limited
Jul 12, 2026
Maintained: Buy
Price Target: $1.09
Current: $0.57
Upside: +91.23%
Cyclopharm Limited
Jul 6, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.59
Upside: +70.94%
Echo IQ Limited
Jul 3, 2026
Downgraded: Hold
Price Target: $1.65 → $1.75
Current: $1.33
Upside: +32.08%
Paradigm Biopharmaceuticals Limited
Jun 18, 2026
Maintained: Buy
Price Target: $0.65 → $0.45
Current: $0.17
Upside: +172.73%
Paragon Care Limited
Jun 2, 2026
Downgraded: Hold
Price Target: $0.30 → $0.17
Current: $0.13
Upside: +36.00%
4DMedical Limited
Jun 2, 2026
Maintained: Buy
Price Target: $4.50 → $6.00
Current: $3.63
Upside: +65.29%
May 28, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.09
Upside: +194.12%
May 21, 2026
Upgraded: Buy
Price Target: $0.20 → $0.24
Current: $0.11
Upside: +118.18%
Apr 14, 2026
Maintained: Buy
Price Target: $240.00 → $226.00
Current: $162.21
Upside: +39.33%
Apr 1, 2026
Maintained: Buy
Price Target: $6.40 → $6.50
Current: $2.37
Upside: +174.26%
Mar 8, 2026
Maintained: Buy
Price Target: $10.00 → $13.00
Current: $11.29
Upside: +15.15%
Feb 24, 2026
Upgraded: Hold
Price Target: $4.10 → $3.60
Current: $3.14
Upside: +14.65%
Dec 17, 2025
Maintained: Buy
Price Target: $0.05 → $0.06
Current: $0.01
Upside: +328.57%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.02
Upside: +733.33%
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.00
Upside: n/a
Nov 25, 2022
Maintained: Hold
Price Target: $4.79 → $3.79
Current: $4.81
Upside: n/a